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Abstract 
Purpose: Kinesiotape is an elastic, adhesive tape applied to the skin that has been used extensively 
to reduce pain associated with various musculoskeletal conditions. Its use in the setting of fractured 
ribs is less clear. The aim of this preliminary study was to investigate the effect of kinesiotaping for 
patients with rib fracture(s) on pain levels, pulmonary function, and mobility. Method: We prospectively 
evaluated five patients admitted with fractured ribs using a single-subject experimental ABAB design. Each 
phase lasted 24 hours with kinesiotape applied during B phases. All participants received usual medical, 
nursing, and allied health care. Outcome measures included pain levels (participant-rated), pulmonary 
function, and maximum mobility. The occurrence of skin irritation was tracked. Results: Considerable 
variability was seen between- and within-participants for pain levels. There was some evidence, albeit 
inconsistent, that pain levels were lower when the kinesiotape was in situ compared to when it was not. 
Pulmonary function and mobility levels showed no consistent pattern between intervention phases. Skin 
irritation occurred in one participant and another required escalation of medical therapy for pneumonia. 
Conclusions: Kinesiotaping may reduce pain for patients with fractured ribs but further research, preferably 
randomized controlled trials with homogenous samples and standardized medication regimens, is 
required to confirm its effectiveness in the acute care setting. 
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ABSTRACT 
Purpose: Kinesiotape is an elastic, adhesive tape applied to the skin that has been used extensively to reduce pain associated 
with various musculoskeletal conditions. Its use in the setting of fractured ribs is less clear. The aim of this preliminary study was 
to investigate the effect of kinesiotaping for patients with rib fracture(s) on pain levels, pulmonary function, and mobility. Method: 
We prospectively evaluated five patients admitted with fractured ribs using a single-subject experimental ABAB design. Each phase 
lasted 24 hours with kinesiotape applied during B phases. All participants received usual medical, nursing, and allied health care. 
Outcome measures included pain levels (participant-rated), pulmonary function, and maximum mobility. The occurrence of skin 
irritation was tracked. Results: Considerable variability was seen between and within participants for pain levels. There was some 
evidence, albeit inconsistent, that pain levels were lower when the kinesiotape was in situ compared to when it was not. Pulmonary 
function and mobility levels showed no consistent pattern between intervention phases. Skin irritation occurred in one participant 
and another required escalation of medical therapy for pneumonia. Conclusions: Kinesiotaping may reduce pain for patients with 
fractured ribs but further research, preferably randomized controlled trials with homogenous samples and standardized medication 
regimens, is required to confirm its effectiveness in the acute care setting. 
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INTRODUCTION 
Rib fractures are a common injury particularly after blunt chest trauma and can result from car/motorbike/bicycle accidents, falls, 
assault, athletic activities, severe coughing, cardiopulmonary resuscitation, and metastatic rib lesions. Patients with fractured ribs 
experience considerable chest wall pain which impairs their ability to take deep breaths, cough, and mobilize.1,2 Management of 
patients hospitalized with fractured ribs includes medications to reduce pain, using modalities including thoracic epidural, regional 
anesthetic blocks, patient-controlled intravenous medication and/or oral analgesics, anti-inflammatory drugs, and physiotherapy to 
optimize pulmonary function and encourage mobility.1,2 Despite these interventions, patients with fractured ribs often experience 
break-through pain that adversely affects their pulmonary function and ability to mobilize.1,2 Due to significant pain, these patients 
are at high risk of developing pulmonary complications such as atelectasis, respiratory tract infection, and ultimately respiratory 
failure, particularly in the setting of pre-existing respiratory disease and other co-morbidities.1,2  
In the first half of the 20th century, semi-rigid strapping of the chest wall was often used for people with fractured ribs to splint and 
immobilize the area and thus reduce pain.3-6 However, over time this practice, particularly strapping that encircled the rib cage, 
was questioned and eventually abandoned as rigid immobilization of the chest wall had the propensity to result in insufficient 
aeration of the underlying lung with an increased risk of lung infection and pneumonia.4-6 As distinct from the semi-rigid strapping 
which restricts movement used in the past, kinesiotaping refers to the application of an elastic, adhesive, cotton-based tape onto 
the skin that was developed in the 1970s. Kinesiotaping is most often used in the management of musculoskeletal injuries such as 
patellofemoral pain, whiplash, and shoulder impingement syndrome.7 Kinesiotaping differs from conventional adhesive taping or 
strapping due to its elasticity, which means it can be stretched longitudinally and therefore support soft tissues and joints without 
restricting underlying movement. In the setting of fractured ribs, both semi-rigid strapping and kinesiotaping have the common aim 
of splinting and supporting the affected area and reducing pain. Theoretically, in contrast to semi-rigid strapping, the elastic nature 
of kinesiotape should not rigidly immobilize the area nor impair pulmonary function. To date, the effectiveness of kinesiotaping has 
predominantly been investigated in musculoskeletal-related conditions, where, as summarized in a systematic literature review 
and meta-analysis by Montalvo et al, it may provide benefits in terms of reduced pain in individuals with musculoskeletal conditions, 
although this reduction may not be clinically important.7  
The mechanism of action by which kinesiotaping may work is not well understood and may involve both ascending and descending 
neurological pathways.7,8 Two studies have investigated the effectiveness of kinesiotaping in the setting of fractured ribs.8,9 
Czyzewski et al found, for 14 in-patients with “one or few” broken ribs, that kinesiotaping significantly reduced pain levels while 
deep breathing, coughing, and changing body position from supine to sitting within 15 minutes of application.8 Sareen et al, in a 
study that involved 10 adult patients with 1-2 undisplaced fractured middle ribs, found that kinesiotaping significantly reduced 
patient-reported rib fracture pain during deep breathing or coughing.9 
The usual practice for patients with fractured ribs admitted to our healthcare center has not included the use of any taping 
techniques, but two recent requests by medical staff for the application of kinesiotape raised our interest in its use. Therefore, the 
purpose of this preliminary study was to investigate the effect of kinesiotaping for patients with rib fracture(s) on pain levels, 
pulmonary function, and mobility while monitoring for the complication of skin irritation. 
METHODS 
Design 
This pilot study utilized a single-subject ABAB design. The study was approved by the Central Adelaide Local Health Network 
Human Research Ethics Committee and registered with the Australian New Zealand Clinical Trials Registry. 
Setting and Participants 
The study was conducted at the Royal Adelaide Hospital, an 800-bed, tertiary-care, urban, public hospital in Australia from 
January to May 2018. Participants were adults (aged ≥ 18 years) admitted under the care of the Royal Adelaide Hospital Trauma 
Service with acute (< 48 hours) rib fracture(s). Exclusion criteria were intubation and mechanical ventilation, presence of other 
major medical conditions/injuries that could affect the biomechanics of the rib cage and/or application of the kinesiotape (e.g. 
underwater sealed drain, spinal injury or fracture, soft tissue injury of the chest wall), previous skin condition in the affected area 
that could be exacerbated by taping (e.g. psoriasis), previous allergy to tape, and an inability to communicate effectively and 
easily in English (e.g. insufficient understanding of English, head injury, cognitive impairment, psychiatric condition). We also 
excluded patients admitted under the care of one particular trauma surgeon who, because of concerns about the potentially 
detrimental effects of kinesiotaping, was unwilling for his patients to participate. 
Methods 
An investigator approached potential participants regarding participation from 0800 hours on day of admission. A written 
information sheet explaining the aims and format of the study was supplied and informed written consent obtained, with the study 
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period commencing later that same morning. Apart from the kinesiotaping, no other aspect of medical, nursing, or allied health 
care was changed. 
The study interventions were provided using an ABAB design, where A = baseline phase (i.e., kinesiotape off) and B = intervention 
phase (i.e., kinesiotape on). Each phase lasted 24 hours, resulting in a total study intervention duration of 4 days. During B phases, 
kinesiotape was applied by one of two investigators between 0800 and 1000 hours and removed 24 hours later. To guide tape 
application, the location of the rib fracture(s) was confirmed by review of the chest x-ray and/or computed tomography (CT) scan 
and the participant indicating their area of greatest pain. Both investigators had previous experience with taping techniques and 
for this study referred to descriptions by Sareen et al and advice from physiotherapy colleagues, including internet resources.9,10  
A length of kinesiotape (50mm width) was initially applied over the area of the fractured rib(s), with ~ 50% tension, and the tape 
extended anteriorly and posteriorly along the margins of the involved ribs (0% tension), with repeated lengths of tape applied as 
required to support the fractured rib(s).9 After completion of the 4-day intervention period, participants were given the option of 
keeping the kinesiotape in situ or removing it, with their choice recorded. 
A training session was held before the study commencement to ensure standardization of testing. The main outcome measure 
was participant-reported pain levels, measured using a verbal analog scale (VAS, where 0 = no pain and 10 = worst pain 
imaginable). Pain was measured at rest, during deep breathing and coughing, and while moving from supine to sitting on two 
occasions during each study phase – the first time between 2-4 hours post-application of kinesiotape in B phases and the second 
time between 4-8 hours post-application of kinesiotape in B phases. In addition, the least and greatest pain in the previous phase 
(i.e., 24 hours) were measured the next morning between 0800 and 1000 before the transition into the next phase of the study. 
Secondary outcomes included pulmonary function and maximum mobility. Forced vital capacity (FVC) was utilized to measure 
pulmonary function.  Following the early VAS pain score being provided by the participant, FVC was recorded as the best of three 
attempts on an EasyOne® spirometer.  Participants’ maximum mobility over each previous 24-hour period was recorded by an 
investigator at the first morning visit using the 0-10 ICU mobility scale (where 0 = nothing, lying in bed and 10 = walking 
independently without a gait aid). The 0-10 ICU mobility scale has been shown to be a feasible tool with strong inter-rater reliability 
for measuring maximum mobility in an ICU setting.11  
The occurrence of any skin irritation/discomfort resulting from the kinesiotaping was documented at the end of each 24-hour period 
using a VAS (where 0 = no skin irritation and 10 = worst skin irritation imaginable) by the participant and one of the two investigators. 
If any major skin irritation (VAS ≥ 5) from kinesiotaping occurred, no further taping was done. After the study (day 5), participants 
were asked to rate the usefulness of the kinesiotaping (VAS, where 0 = no use and 10 = maximum usefulness imaginable). 
Participants’ medical records were reviewed by an investigator at every visit to ascertain the occurrence of any respiratory 
complications (e.g. respiratory infection, lobar collapse, sputum retention) or escalation of respiratory support (e.g. higher level of 
supplemental oxygen, need for non-invasive or invasive mechanical ventilation).  
Basic demographic and descriptive data were recorded for each participant including sex, age, past medical history, primary 
diagnosis, time post-injury, number/location/displacement of rib fractures and management thereof, analgesia, other 
injuries/conditions, and hospital length of stay. 
Data Analyses 
Given the single-subject study design, individual data are primarily reported and visually analyzed using figures. No statistical 
analyses were undertaken. 
 
RESULTS 
Study Participants 
Five participants were recruited, with their baseline demographics and clinical data shown in Table 1. All participants fractured their 
ribs as a result of blunt trauma and all rib fractures were diagnosed using a combination of x-ray and CT findings. Three of the 5 
participants (no. 1, 2 and 4) had no displacement of their rib fractures, with minimal displacement seen for the other 2 participants 
(no. 3 and 5). One participant (no. 4) was discharged from hospital on the morning of day 4 so had no outcomes measured thereon. 
Figure 1 shows the kinesiotaping in situ for one participant. 
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Figure 1. Kinesiotaping In Situ for One Participant (no. 5).
 
Table 1. Participants’ Demographic and Clinical Data 
Subject 
number 
Sex Age 
(years) 
Mechanism of 
injury 
Ribs fractured Other injuries Relevant past 
medical history 
Hospital 
length of 
stay (days) 
1 F 63 MVA L anterolateral 4-
9, R anterolateral 
3-9 
Sternal 
fracture 
COPD, obesity, 
current smoker 
9.2 
2 M 19 MBA L posterior 2-4 Splenic 
laceration, 
fractured L 
iliac wing 
N/A 7.7 
3 F 66 Fall from 
ladder 
L anterior 5-8 Nil COPD, OA, 
obesity, 
depression 
5.5 
4 M 58 Bicycle 
accident 
R posterolateral 
3-7 
R scapula 
fracture 
R shoulder 
surgery for 
dislocation 
3.9 
5 M 49 Bicycle 
accident 
R lateral 2-8 R clavicle 
fracture 
Lumbar 4/5 
laminectomy 
7.0 
F = female, M = male, MVA = motor vehicle accident, L = left, R = right, MBA = motorbike accident, COPD = chronic obstructive 
pulmonary disease, OA = osteoarthritis.  
 
Pain Scores 
The pain scores at rest, during deep breathing and coughing, and while moving from supine to sitting for the 5 participants during 
the ABAB phases of the study are shown in Figures 2-4. As can be seen, there was considerable variability between participants 
in pain scores across the phases of the study. While no consistent pattern was evident, pain scores were, arguably, somewhat 
lower on the days when the kinesiotape was applied, evident in the mean (SD) values for the 5 participants shown in Table 2. In 
particular, when phases B1 (i.e., first application of kinesiotape, Day 2) and A2 (i.e., second baseline phase, Day 3) are compared, 
a decrease in pain would have been anticipated due to natural recovery over time, whereas the opposite was seen in that most 
pain levels were higher in A2 than B1 phases (Figures 2-4, Table 2). No clear pattern was evident for the least and greatest pain 
reported by participants (Table 2). 
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Figure 2. VAS Pain Levels at Rest for the 5 Participants Over the Phases of the Study.
 
Figure 3. VAS Pain Levels During Deep Breathing and Coughing for the 5 Participants Over the Phases of the Study. 
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Figure 4.  VAS Pain Levels While Moving From Supine to Sitting on the Edge of the Bed for the 5 participants Over the Phases 
of the Study. 
 
 
Table 2. Mean (SD) VAS Pain Scores for the 5 Participants 
Outcomes Day 1, phase A1 
(no kinesiotaping) 
n = 5 
Day 2, phase B1 
(kinesiotaping) 
n = 5 
Day 3, phase A2 
(no kinesiotaping) 
n = 5 
Day 4, phase B2 
(kinesiotaping) 
n = 4 
Morning 
 At rest 
 During deep B&C 
 Whilst moving 
Afternoon 
 At rest 
 During deep B&C 
 Whilst moving 
Least pain in last 24 hours 
Greatest pain in last 24 hours 
 
2.6 (1.1) 
5.6 (1.5) 
6.0 (2.5) 
 
3.6 (2.7) 
6.0 (3.2) 
6.4 (1.7) 
1.6 (1.3) 
7.6 (1.8) 
 
1.8 (0.8) 
3.2 (1.1) 
4.8 (1.6) 
 
1.8 (1.3) 
4.8 (1.5) 
5.6 (1.9) 
1.4 (1.3) 
7.6 (1.8) 
 
2.8 (0.8) 
5.4 (1.1) 
5.4 (1.6) 
 
2.0 (1.3) 
5.2 (1.5) 
5.8 (1.9) 
1.2 (1.3) 
8.1 (2.4) 
 
1.3 (1.0) 
4.5 (1.0) 
4.8 (3.3) 
 
1.0 (1.4) 
4.5 (2.5) 
4.5 (2.4) 
0.8 (1.0) 
4.8 (1.5) 
 
Other Outcomes 
Values for FVC (percentage predicted) were markedly variable between participants and across the study phases, with two 
participants (no. 1 and 2) showing an improvement in FVC over time, two participants (no. 4, 5) staying fairly static and the other 
(no. 3) showing a fall in FVC over the study period. No clear pattern was evident between the study phases. Maximum mobility 
levels showed a ceiling effect for three participants (no. 3, 4, 5) with the other two participants (no. 1 and 2) demonstrating an 
improvement in maximum mobility over time. There was no clear difference between study phases for maximum mobility levels. 
Four of the five participants (no. 1, 2, 3, 4) self-reported zero skin irritation (VAS) from the kinesiotaping across the study period, 
with the fifth participant (no. 5) rating his skin irritation as 3 on day 4 and 0 on day 5. Skin irritation rated by the treating 
KINESIOTAPING EFFECTIVENESS 6 
 
 
 
© The Internet Journal of Allied Health Sciences and Practice, 2020 
 
physiotherapist was zero for 2 participants (no. 3, 4), 3 or less for 2 participants (no. 1, 2). The remaining participant (no. 5) was 
rated 7 on days 4 and 5, with redness, edema, and papules/vesicles apparent, necessitating removal of the tape. No specific 
intervention for skin irritation was required for any participant. 
 
The usefulness of the kinesiotaping was rated as 5, 6, 9, 6 and 5 on the VAS for the 5 participants respectively. Three participants 
(no. 1, 3, 4) chose to leave the tape on after the intervention period. Comments from the participants were as follows: "The tape is 
no bother.” (no. 1); “The days the tape was on [I] didn’t feel any pain around the fracture site at times. More comfortable with tape 
on.” (no. 2); “Really good, worthwhile, holds you all the time.” (no. 3); “Felt it helped a little.” (no. 4); “Felt more stable with tape on. 
Flexible, comfort.” (no. 5). 
 
Multimodal analgesia was used for pain control and showed considerable variability between participants. All received intravenous 
fentanyl (patient-controlled analgesia), oral tramadol, and oral paracetamol. Four participants also received oral oxycodone (no. 2, 
3, 4, 5), 3 received an intravenous ketamine infusion (no. 1, 4, 5), and oral ibuprofen (no. 2, 4, 5). One participant (no. 1) was given 
a sternal block using a local anesthetic on day 1, and one participant (no. 3) received oral pregabalin. The types and dosages of 
analgesia decreased over the study duration for all participants. 
 
Review of participants’ medical records showed that four participants (no. 2-5) remained in a stable medical condition, with gradual 
clinical improvement and de-escalation of medical intervention over the study duration. One participant (no. 1), with bilateral rib 
fractures, and a significant past medical history of chronic obstructive lung disease, obesity, and smoking, developed pneumonia 
on day 4, necessitating intravenous antibiotics, from which she made an otherwise uneventful recovery. 
 
DISCUSSION 
The aim of this preliminary study was to investigate the effect of kinesiotaping for patients with rib fracture(s) on pain levels, 
pulmonary function, and mobility, with monitoring for skin irritation complications using a single-subject study design. 
Considerable variability was seen between participants and across study phases for pain scores. While no clear effect was 
evident there were lower pain scores and less variability on the days of kinesiotape application. Kinesiotaping did not appear to 
have a consistent effect on pulmonary function or maximum mobility. Marked skin irritation, necessitating the removal of the 
kinesiotape, occurred for one participant and the medical condition of one participant deteriorated due to the development of 
pneumonia, necessitating antibiotics. The marked heterogeneity of the patient sample, in terms of their rib injuries, concomitant 
injuries, co-morbidities, and analgesic regimen made comparisons between participants difficult. 
 
The magnitudes of the reductions in rib fracture pain that we documented with kinesiotaping were similar to those reported by 
Czyzewski et al and Sareen et al, where VAS pain levels during deep breathing and coughing decreased in the order of 1.5 points 
immediately after the application of kinesiotaping.8,9 The incidence of skin irritation that we documented, with 3 of 5 participants 
having skin irritation scores greater than zero (only 1 had major skin irritation), was higher than that reported previously for 
kinesiotaping. For example, Brockman and Klein and Imperatori et al observed no local skin reaction from kinesiotaping applied to 
46 patients after pulmonary lobectomy and 23 patients after median sternotomy respectively.12,13 It is possible that our ABAB study 
design, which necessitated the repeated application and removal of kinesiotaping across study phases, may have contributed to 
the skin irritation we documented. A single application of kinesiotaping may not have produced the same degree of skin irritation. 
Given our results, future studies investigating the effect of kinesiotaping for fractured ribs should document the frequency and 
severity of skin irritation. One participant in our study required antibiotics when she developed pneumonia. Her pre-existing medical 
conditions and severity of her rib fractures put her in a particularly high-risk category. Although unlikely, we cannot exclude the 
possibility that the kinesiotaping contributed to the development of pneumonia. 
 
The clinical significance of our findings is unclear. Our anecdotal opinion, based on experience during this trial, is that kinesiotaping 
seemed most effective for those patients with unilateral rib fractures without extensive co-morbidities. Further research, preferably 
randomized controlled studies with larger sample sizes, is required to confirm and extend our results. However, the heterogeneous 
nature of this patient group, with respect to the nature of their rib fractures, concomitant injuries, past medical history, and analgesic 
management, will make it difficult to obtain comparable treatment groups in any future studies. It would also be of interest to 
undertake a study where different types of non-rigid strapping/taping are compared. While the reductions in pain levels that we 
documented were variable and relatively small, our impression was that pain was the outcome measure that best reflected any 
effect of kinesiotaping. 
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Limitations 
Our study had several important limitations. Our sample demonstrated marked heterogeneity in terms of their injuries, co-
morbidities, and analgesic management. Historically, this heterogeneity is typical of patients requiring hospital admission for rib 
fractures. It is clear that analgesic medication has a major role to play in the management of fractured ribs and we acknowledge 
the analgesics the participants received impacted the outcomes measured in this study. While it would have been preferable to 
have had a standardized analgesic regimen, this was beyond the scope of our introductory study. Another limitation is that the 
ABAB design of our study introduced the potential for an order effect, with spontaneous recovery over time being responsible for 
the improved outcomes seen during B phases (i.e., B1 and B2 phases on days 2 and 4) rather than the kinesiotaping. However, if 
our results are examined in more detail, lower pain levels were generally seen on day 2 (i.e., phase B1, kinesiotape on) compared 
to day 3 (i.e., phase A2, kinesiotape off), whereas the opposite result would be expected with spontaneous recovery alone. This 
finding suggests but does not prove that kinesiotaping seemed to reduce pain levels. Lastly, we did not attempt to investigate the 
mechanism by which kinesiotaping may have had its effect. Despite the introductory and exploratory nature of our study, we believe 
the results provide valuable information that can be used to inform future research. 
 
CONCLUSION 
This preliminary study found that kinesiotaping has the potential to reduce pain for patients with fractured ribs. However, given the 
exploratory nature of this study, further research is required, preferably randomized controlled trials with more homogenous 
samples and standardized analgesic regimens to clarify the effectiveness of kinesiotaping in the reduction of pain, improvement of 
pulmonary function and mobility following rib fractures. 
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